- Home
- OB vs KRRO Comparison
OB vs KRRO Comparison
Compare OB & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OB
- KRRO
- Stock Information
- Founded
- OB 2006
- KRRO 2014
- Country
- OB United States
- KRRO United States
- Employees
- OB N/A
- KRRO N/A
- Industry
- OB Industrial Machinery/Components
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- OB Industrials
- KRRO Health Care
- Exchange
- OB Nasdaq
- KRRO Nasdaq
- Market Cap
- OB 259.3M
- KRRO 209.6M
- IPO Year
- OB 2021
- KRRO 2019
- Fundamental
- Price
- OB $2.58
- KRRO $11.82
- Analyst Decision
- OB Buy
- KRRO Strong Buy
- Analyst Count
- OB 5
- KRRO 7
- Target Price
- OB $7.08
- KRRO $85.67
- AVG Volume (30 Days)
- OB 516.3K
- KRRO 89.6K
- Earning Date
- OB 05-09-2025
- KRRO 05-07-2025
- Dividend Yield
- OB N/A
- KRRO N/A
- EPS Growth
- OB N/A
- KRRO N/A
- EPS
- OB N/A
- KRRO N/A
- Revenue
- OB $959,268,000.00
- KRRO $4,821,000.00
- Revenue This Year
- OB $67.66
- KRRO $20.96
- Revenue Next Year
- OB N/A
- KRRO N/A
- P/E Ratio
- OB N/A
- KRRO N/A
- Revenue Growth
- OB 4.15
- KRRO N/A
- 52 Week Low
- OB $2.57
- KRRO $11.00
- 52 Week High
- OB $7.87
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- OB 31.80
- KRRO 34.02
- Support Level
- OB $2.60
- KRRO $14.54
- Resistance Level
- OB $2.89
- KRRO $16.68
- Average True Range (ATR)
- OB 0.18
- KRRO 1.49
- MACD
- OB -0.01
- KRRO -0.33
- Stochastic Oscillator
- OB 1.21
- KRRO 6.24
About OB Outbrain Inc.
Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.